GlassScriptPhysician profile
Skyler J King
NPI 1407217920
$24,160.21
in general payments reported to CMS, 2019-2025
12 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,342 · 2020: $19.03 · 2021: $2,424 · 2022: $15K · 2023: $1,469 · 2024: $1,797 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,308 · Travel and Lodging: $1,290 · Education: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,308.43 |
| Travel and Lodging | $1,290.02 |
| Education | $685.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,971.41 | 2022-2023 | Shoulder Implants Fibertak Knotless |
| Legacy Ortho LLC | $4,800.00 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $4,259.74 | 2022-2024 | Oxford, Oxford Partial Knee |
| Crossroads Orthopedics, LLC | $3,610.08 | 2022 | |
| Stryker Corporation | $2,944.78 | 2022-2025 | Tornier Perform Reversed Augmented Glenoid, Aequalis Perform+, Bio4 |
| Cdc Medical LLC | $2,342.00 | 2019 | |
| Linvatec Corporation | $878.18 | 2023-2025 | Biobrace 23mm, Livatec Knee Preservation System, Linvatec Shoulder Arthroscopy |
| Novus Surgical Consultants | $150.00 | 2023 | |
| Alphatec Spine, INC | $142.46 | 2025 | |
| Avanos Medical | $43.07 | 2020-2021 | |
| Sanara Medtech INC. | $13.45 | 2024 | Celleraterx |
| Orthofix Medical, INC. | $5.04 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Skyler King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.